Therapeutic effect on MSCs | Method/finding | Source of MSCs | Wound-healing model | Reference |
---|---|---|---|---|
Increased delivery | Three-dimensional collagen allograft | Rat bone marrow | Rat | [29] |
 | Microsphere-based engineered skin loaded with EGF | Mouse bone marrow | Mouse | [31] |
Increased migration | CXCL12/CXCR4 axis | Mouse bone marrow | Mouse | [32] |
 | Platelet-rich plasma | Human amniotic fluid | Human | [34] |
 | EMPB | Mouse | Mouse | [35] |
Increased survival | Biomimetic pullulan-based hydrogel | Mouse | Mouse | [36] |
Increased immunomodulation | Polarization of macrophages to M2 phenotype | Human gingival tissue | Mouse | [37] |
 | Increased miRNA-146a | Mouse bone marrow | Mouse | [16] |
 | MSC-derived TSG-6 | Human bone marrow | Mouse | [42] |
Increased angiogenesis | Biomimetic hydrogel scaffold | Mouse bone marrow | Mouse | [43] |
 | LLLT | Dog adipose tissue | Mouse | [44] |
 | 14S,21R-diHDHA | Mouse | Mouse | [45] |
 | v-myc introduction | Human adipose tissue | Mouse | [47] |
Increased wound-healing efficacy | Hypoxia | Human amniotic fluid | Mouse | [49] |
 | Hypoxia | Human adipose tissue | Mouse | [50] |
 | Hypoxia | Human bone marrow | Mouse | [51] |